Press releases

2022

2022-11-25 11:10 First treatment with Q-PRO[®] and integrated image management technology Regulatory
2022-11-21 13:00 Skåne University Hospital in Malmö is included in the clinical trial for treatment of recurrent prostate cancer Regulatory
2022-11-03 09:00 SpectraCure has registered the trademark Q-PRO[®] Regulatory
2022-09-19 12:00 SpectraCure's new treatment system has been approved in the UK for use in clinical trials Regulatory
2022-08-30 11:00 Patent regarding the new generation of treatment systems approved in Europe Regulatory
2022-07-18 19:10 SpectraCure’s CEO is leaving the company Regulatory MAR
2022-06-20 12:00 Software for improved imaging technology is approved for use in clinical study in the US Regulatory
2022-06-07 14:15 SpectraCure has been approved a grant from EU of € 125,000 Regulatory
2022-06-03 11:30 Patent approved in Europe Regulatory
2022-05-16 11:00 A new Board has been installed at SpectraCure
PreviousNext